KPP Advisory Services LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 37.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,300 shares of the healthcare conglomerate's stock after purchasing an additional 1,458 shares during the quarter. KPP Advisory Services LLC's holdings in UnitedHealth Group were worth $1,654,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Nuveen LLC purchased a new position in shares of UnitedHealth Group during the 1st quarter worth $3,846,764,000. Vanguard Group Inc. increased its position in shares of UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after acquiring an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP lifted its holdings in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares during the last quarter. National Bank of Canada FI increased its holdings in UnitedHealth Group by 137.8% in the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate's stock valued at $859,518,000 after purchasing an additional 950,928 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock worth $3,702,736,000 after buying an additional 847,054 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.
UnitedHealth Group Trading Down 3.0%
Shares of UnitedHealth Group stock opened at $354.52 on Thursday. The company has a fifty day simple moving average of $335.48 and a 200-day simple moving average of $341.42. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $321.08 billion, a price-to-earnings ratio of 15.42, a PEG ratio of 2.36 and a beta of 0.47.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business's revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.
Analysts Set New Price Targets
Several analysts have recently issued reports on the stock. The Goldman Sachs Group began coverage on shares of UnitedHealth Group in a research report on Tuesday, October 14th. They set a "buy" rating and a $406.00 price target on the stock. Weiss Ratings reissued a "sell (d+)" rating on shares of UnitedHealth Group in a research report on Wednesday, October 8th. Barclays lifted their target price on UnitedHealth Group from $352.00 to $386.00 and gave the company an "overweight" rating in a report on Thursday, October 9th. Royal Bank Of Canada decreased their price objective on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and set a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Eighteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $385.13.
Read Our Latest Stock Report on UNH
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.